TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PharMedCon Europe AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
825
|
2,064
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
468
|
1,621
|
-24 |
| EBITDA |
444
|
1,608
|
-24 |
| Total assets |
3,645
|
3,253
|
1,655 |
| Current assets |
858
|
1,126
|
25 |
| Current liabilities |
64
|
122
|
10 |
| Equity capital |
3,430
|
3,010
|
1,615 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
94.1%
|
92.5%
|
97.6% |
| Turnover per employee |
825
|
2,064 | |
| Profit as a percentage of turnover |
56.7%
|
78.5% | |
| Return on assets (ROA) |
12.8%
|
49.8%
|
-1.5% |
| Current ratio |
1340.6%
|
923.0%
|
250.0% |
| Return on equity (ROE) |
13.6%
|
53.9%
|
-1.5% |
| Change turnover |
-1,276
|
2,064
|
0 |
| Change turnover % | -61% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.